2024. TIRZEPATIDE, A DUAL GIP AND GLP-1 RECEPTOR AGONIST, IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: EFFICACY AND SAFETY. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. 5, 4 (Apr. 2024), e545133. DOI:https://doi.org/10.47820/recima21.v5i4.5133.